President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce ...
President Donald Trump on Thursday announced a deal with drugmakers Eli Lilly and Novo Nordisk to lower prices for their GLP-1 medications Zepbound and Wegovy, widely used for weight loss.
Trump's plan calls for lowering the cost of fertility treatments and eliminating red tape for employers who want to expand access for workers.
Trump unveils deal to expand coverage and lower costs on obesity drugs Wegovy and Zepbound.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback